Trifork Investor Conference Presentation Deck

27 Labs Segment Performance EBT (EURM) 9.8 2018 9.0 2019 39.2 2020 3.3 2021 1.2 Q1 2021 1.2 Q1 2022 INVESTMENTS (EURM) Cash / cost in active investments Acc. unrealized gain Acc. realized gain 10.7 17.5 2.2 2018 10.7 28.8 3.7 2019 11.0 70.4 5.5 2020 69.6 16.7 30.6 (1) 2021 (1) 2021 Dawn Health deconsolidation/conversion was EURm 20.3 69.6 18.0 38.8 Q1/2022 TRIFORK.

View entire presentation